Pre-exposure prophylaxis (PrEP) is the advent of antiretroviral treatment use for people at increased risk of acquiring HIV-1 ...

While PrEP can prevent HIV, it does not protect against other sexually transmitted infections or pregnancy. PrEP stand for pre-exposure prophylaxis. This means it prevents you from getting HIV by ...

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...

Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of ...

Utilizing syringe service programs to provide comprehensive PrEP care shows promise for encouraging more people who inject ...

Both drugs are concentrated in genital secretions as compared to plasma which is desirable for a pre-exposure prophylaxis (PrEP) agent. The signature mutations for TDF resistance are K65R and K70E ...

An end-to-end digital PrEP pathway appeared to improve accessibility, inclusivity, and service satisfaction among LGBTQ+ ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and ...

Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...

Sciences presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of ...